StoxAcutaas Chemicals vs Aarti Industries: share price & financials comparison
NSE: ACUTAAS vs AARTIIND · Healthcare · as of 13 Nov 2026
Both prices rebased to 100 at the start of the selected period.
Acutaas Chemicals vs Aarti Industries at a glance
Acutaas Chemicals (ACUTAAS) has a market capitalisation of ₹33,069 Cr, against ₹17,482 Cr for Aarti Industries (AARTIIND). Over the past year Acutaas Chemicals has returned +120.2%, compared with +25.1% for Aarti Industries. On valuation, Aarti Industries trades at a lower P/E of 39.9 versus 75.3. Acutaas Chemicals earns a higher return on equity (23.6% vs 7.0%). Acutaas Chemicals comes out ahead on profitability, growth, financial health, momentum and technicals. Aarti Industries comes out ahead on size and valuation. Across the scored metrics below, Acutaas Chemicals leads on 12 and Aarti Industries on 5. On StoxGud's 10-point checklist, Acutaas Chemicals scores 8/10 and Aarti Industries scores 6/10.
| Metric | Acutaas Chemicals | Aarti Industries |
|---|---|---|
| Size | ||
| Market cap | ₹33,069 Cr | ₹17,482 Cr |
| Revenue (latest FY) | ₹1,339 Cr | ₹8,286 Cr |
| Net profit (latest FY) | ₹356 Cr | ₹419 Cr |
| Valuation | ||
| P/E | 75.3 | 39.9 |
| P/B | 17.80 | 2.79 |
| Dividend yield | 0.04% | 0.21% |
| Profitability | ||
| Return on equity | 23.6% | 7.0% |
| Net profit margin | 27.6% | 4.1% |
| Operating margin | 39.1% | 13.8% |
| Growth | ||
| Revenue growth (YoY) | +42.7% | +74.7% |
| Net profit growth (YoY) | +73.3% | +58.8% |
| Revenue CAGR (multi-year) | +26.7% | +13.0% |
| Financial health | ||
| Debt to equity | 0.00 | 0.82 |
| Momentum | ||
| 1-month return | +27.1% | -1.2% |
| 1-year return | +120.2% | +25.1% |
| 3-year CAGR | +95.5% | -2.4% |
| 5-year CAGR | +52.3% | -13.0% |
| 10-year CAGR | — | +10.8% |
| Distance from 52W high | +0.0% | -11.3% |
| Technicals | ||
| RSI (14) | 79 | 79 |
| Price vs 200-day avg | +38.5% | +3.5% |
Highlighted cells lead on that metric. Market cap, revenue and RSI are shown for context and not scored.
10-point checklist side by side
| Check | Acutaas Chemicals | Aarti Industries |
|---|---|---|
| Price above 50-day average | ✓ | ✓ |
| Price above 200-day average | ✓ | ✓ |
| 50-day average above 200-day (uptrend) | ✓ | ✓ |
| RSI in healthy 40–70 zone | ✗ | ✗ |
| Positive 1-year return | ✓ | ✓ |
| Return on equity above 15% | ✓ | ✗ |
| Debt to equity below 1 | ✓ | ✓ |
| Revenue growing year on year | ✓ | ✓ |
| Net profit margin above 10% | ✓ | ✗ |
| P/E below industry median | ✗ | ✗ |
| Score | 8/10 | 6/10 |
A rules-based screen for education only — not a buy or sell recommendation.
FAQs
Which is bigger, Acutaas Chemicals or Aarti Industries?
Acutaas Chemicals has a market cap of ₹33,069 Cr and Aarti Industries has a market cap of ₹17,482 Cr as of 13 Nov 2026.
Which has a lower P/E, Acutaas Chemicals or Aarti Industries?
Aarti Industries has the lower P/E: Acutaas Chemicals trades at 75.3 and Aarti Industries at 39.9.
Which gave better returns in the last year, Acutaas Chemicals or Aarti Industries?
Acutaas Chemicals did better: Acutaas Chemicals returned +120.2% and Aarti Industries returned +25.1% over one year.
What is the difference between Acutaas Chemicals and Aarti Industries?
Both are NSE-listed companies in Healthcare. Acutaas Chemicals is about 1.9 times the size of Aarti Industries by market cap. In the latest financial year Acutaas Chemicals reported revenue of ₹1,339 Cr and Aarti Industries ₹8,286 Cr. Operating margin is 39.1% for Acutaas Chemicals and 13.8% for Aarti Industries. Debt to equity is 0.00 for Acutaas Chemicals and 0.82 for Aarti Industries.
Which is better, Acutaas Chemicals or Aarti Industries?
It depends on what you are looking for, and StoxGud does not recommend either stock. On the metrics compared above, Acutaas Chemicals leads on 12 and Aarti Industries on 5. Acutaas Chemicals is ahead on profitability, growth, financial health, momentum and technicals. Aarti Industries is ahead on size and valuation. On StoxGud's rules-based checklist Acutaas Chemicals scores 8/10 and Aarti Industries scores 6/10. This is information, not advice: consult a SEBI-registered adviser before investing.